The Chase Group Successfully Completes Vice President, Clinical Development, Respiratory for Ionis Pharmaceuticals
The Chase Group appreciates and values our continued partnership with Ionis Pharmaceuticals and is pleased to announce the successful completion of the Vice President, Clinical Development, Respiratory search. The successful candidate has completed his first month in the organization and is already considered a valued member of the drug development team. Congratulations to Ionis for securing a tremendous new leader.
Ami Claxton, MS, PhD has joined Ionis Pharmaceuticals, Inc. as Director, Global HEOR Rare Disease Immunology. She will play a critical and significant role as…
The Chase Group is pleased to announce the successful completion of the Vice President, Medical Affairs search for Avidity Biosciences. Nathan Weedin brings 15+ years…
Ionis Pharmaceuticals has a 35-year track record of perfecting and advancing RNA-targeted drug discovery and development. Projecting a vast number of new transformational products on…
In late 2022, Arcturus Therapeutics retained The Chase Group to build out additions to the leadership team. Tasked with identifying the new Chief Medical Officer,…
The Chase Group is pleased to announce the successful recruitment of Elvis Osei Tutu, PharmD, as the Vice President, Head of Regulatory Affairs at Checkmate…
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike…